Roland Alexander Maier
Vorstandsvorsitzender bei Techplus Asset Management AG
Profil
Mr. Roland A.
Maier is a Portfolio Manager & Analyst at Techplus Asset Management AG.
Mr. Maier was a Partner of Medex Advisors LLP, London, UK, from 2012 to 2015.
Before this, he served for ten years, from 1999 to 2009, as a portfolio manager of BB Biotech, one of the most prominent financial investors in biotechnology, with several billion dollars assets under management.
Between 2003 and 2009, he was the head of the management team of BB Biotech.
In parallel, between 2006 and 2007, he served as the CEO of Bellevue Asset Management AG.
Before this, Mr. Maier served for three years at the corporate development of BASF Pharma, the pharmaceutical branch of BASF AG.
He studied biochemistry at the University of Tübingen and the ETH Zürich.
In addition, he studied business administration and finance at the University of St. Gallen.
Aktive Positionen von Roland Alexander Maier
| Unternehmen | Position | Beginn |
|---|---|---|
Techplus Asset Management AG
 Techplus Asset Management AG Investment ManagersFinance Techplus Asset Management AG is an independent asset management firm headquartered in Wollerau, Switzerland. Founded in 2004, the firm advises a healthcare fund that specializes in biotechnology. | Vorstandsvorsitzender | 01.03.2004 |
Ehemalige bekannte Positionen von Roland Alexander Maier
| Unternehmen | Position | Ende |
|---|---|---|
Medex Capital Ltd.
 Medex Capital Ltd. Investment ManagersFinance Medex Capital Ltd. is a privately-owned, UK-based alternative investment firm which was founded by Bartjan van Hulten in 2011 as Van Hul Ten Ltd. Headquartered in London, the firm manages assets of sophisticated investors. | Analyst-Equity | 01.01.2015 |
Bellevue Asset Management AG
 Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Vorstandsvorsitzender | 01.01.2007 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |
Medex Capital Ltd.
Medex Capital Ltd. Investment ManagersFinance Medex Capital Ltd. is a privately-owned, UK-based alternative investment firm which was founded by Bartjan van Hulten in 2011 as Van Hul Ten Ltd. Headquartered in London, the firm manages assets of sophisticated investors. | Finance |
Techplus Asset Management AG
Techplus Asset Management AG Investment ManagersFinance Techplus Asset Management AG is an independent asset management firm headquartered in Wollerau, Switzerland. Founded in 2004, the firm advises a healthcare fund that specializes in biotechnology. | Finance |
